Methodological quality and reporting quality evaluation of randomized controlled trials published in China Journal of Chinese Materia Medica.
10.19540/j.cnki.cjcmm.20171107.003
- Author:
Dan-Dan YU
1
;
Yan-Ming XIE
1
;
Xing LIAO
1
;
Ying-Jie ZHI
1
;
Jun-Jie JIANG
1
;
Wei CHEN
2
Author Information
1. Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. Beijing University of Chinese Medicine, Beijing 100029, China.
- Publication Type:Journal Article
- Keywords:
CONSORT;
quality evaluation;
randomized controlled trial;
risk of bias
- MeSH:
China;
Humans;
Materia Medica;
Medicine, Chinese Traditional;
Publications;
Randomized Controlled Trials as Topic;
standards
- From:
China Journal of Chinese Materia Medica
2018;43(4):833-839
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the methodological quality and reporting quality of randomized controlled trials(RCTs) published in China Journal of Chinese Materia Medica, we searched CNKI and China Journal of Chinese Materia webpage to collect RCTs since the establishment of the magazine. The Cochrane risk of bias assessment tool was used to evaluate the methodological quality of RCTs. The CONSORT 2010 list was adopted as reporting quality evaluating tool. Finally, 184 RCTs were included and evaluated methodologically, of which 97 RCTs were evaluated with reporting quality. For the methodological evaluating, 62 trials(33.70%) reported the random sequence generation; 9(4.89%) trials reported the allocation concealment; 25(13.59%) trials adopted the method of blinding; 30(16.30%) trials reported the number of patients withdrawing, dropping out and those lost to follow-up;2 trials （1.09%） reported trial registration and none of the trial reported the trial protocol; only 8(4.35%) trials reported the sample size estimation in details. For reporting quality appraising, 3 reporting items of 25 items were evaluated with high-quality,including: abstract, participants qualified criteria, and statistical methods; 4 reporting items with medium-quality, including purpose, intervention, random sequence method, and data collection of sites and locations; 9 items with low-quality reporting items including title, backgrounds, random sequence types, allocation concealment, blindness, recruitment of subjects, baseline data, harms, and funding;the rest of items were of extremely low quality(the compliance rate of reporting item<10%). On the whole, the methodological and reporting quality of RCTs published in the magazine are generally low. Further improvement in both methodological and reporting quality for RCTs of traditional Chinese medicine are warranted. It is recommended that the international standards and procedures for RCT design should be strictly followed to conduct high-quality trials. At the same time, in order to improve the reporting quality of randomized controlled trials, CONSORT standards should be adopted in the preparation of research reports and submissions.
